Patents by Inventor Narendra Lalwani

Narendra Lalwani has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • TRIPLET COMBINATION FORMULATIONS AND METHODS FOR TREATING OR REDUCING THE RISK OF CARDIOVASCULAR DISEASE
    Publication number: 20210361618
    Abstract: Disclosed herein are compositions comprising ETC-1002; Ezetimibe; a statin; and one or more pharmaceutical excipients or carriers. Also disclosed herein are methods for using said composition. Uses include methods of treating cardiovascular disease or reducing the risk of cardiovascular disease in a subject. Uses also include methods of treating hypercholesterolemia and/or dyslipidemias in a subject.
    Type: Application
    Filed: February 8, 2018
    Publication date: November 25, 2021
    Inventors: Narendra Lalwani, Diane MacDougall
  • Methods of using non-human animal Apoliprotein A-I protein
    Publication number: 20060014692
    Abstract: The invention provides methods and compositions for treating disorders using non-human animal Apolipoprotein A-I (ApoA-I) protein. The invention provides methods and compositions for treating disorders in animals, including humans, associated with dyslipidemia, including hyperlipidemia, hyperlipoproteinemia, hypertriglyceridemia, hypercholesterolemia, HDL deficiency, ApoA-I deficiency, cardiovascular disease, atherosclerosis, restenosis, and other disorders such as septic shock and viral infections.
    Type: Application
    Filed: September 8, 2005
    Publication date: January 19, 2006
    Inventors: Lingyu Zhu, Narendra Lalwani, Jean-Louis Dasseux
  • Pharmaceutical formulations, methods, and dosing regimens for the treatment and prevention of acute coronary syndromes
    Publication number: 20050142180
    Abstract: The invention provides methods and formulations for treating and preventing acute coronary syndromes. The methods of the instant invention provide safe and effective doses of an Apolipoprotein A-I Milano: phospholipid complex to reduce and stabilize atherosclerotic plaque. Pharmaceutical formulations of the Apo A-I Milano:phospholipid complexes are also provided.
    Type: Application
    Filed: October 15, 2004
    Publication date: June 30, 2005
    Inventors: Charles Bisgaier, Narendra Lalwani, Wendi Rodrigueza, Daniel Hartman, Jan Johansson